<DOC>
	<DOCNO>NCT01281007</DOCNO>
	<brief_summary>Recurrent genital herpes commonly occur sexually transmit disease cause herpes simplex virus ( HSV ) . There effective oral prescription antiviral medicine available reduce discomfort symptom , famciclovir aciclovir . This phase III , multicenter , randomize , parallel-group study compare efficacy safety treatment famciclovir ( 125 mg ) versus aciclovir ( 200 mg ) patient active recurrent genital herpes .</brief_summary>
	<brief_title>Efficacy Oral Famciclovir 125mg Comparing Aciclovir 200 mg Treatment Patients With Active Recurrent Genital Herpes</brief_title>
	<detailed_description>STUDY DESIGN - Open-label , prospective , parallel group , intent treat trial - Experiment duration : 5 day - 2 visit ( day 1 , 5 ) - Reduction symptom - Adverse event evaluation</detailed_description>
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients must able understand study procedure agree participate give write consent . 2 . Patients clinical diagnosis recurrent genital herpes ; 3 . Score symptoms high 4 ; 4 . Negative pregnant urine test . Exclusion criterion : 1 . Pregnancy risk pregnancy . 2 . Lactation 3 . Any pathology past medical condition interfere protocol . 4 . Nonsteroidal antiinflammatory drug , hormonal antiinflammatory immunosuppressive drug ( last 30 day study ) ; 5 . Patients immunodeficiency and/or immunosuppressive disease ; 6 . Hypersensitivity component formula ; 7 . Other condition deem reasonable medical investigator disqualification individual study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Herpes Simplex Virus</keyword>
</DOC>